Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the company's share price ...

If child with a high BMI reaches a healthy weight by the age of six, they are no longer at risk of becoming obese later in ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their ...

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Deaths attributed to both acute heart attack and obesity rose between 2007 and 2019, according to findings from the CDC ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

Alabama has moved up the most recent obesity rankings from U.S. News & World Report. And we’re getting awfully close to the ...

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...